Screening for hypertensive organ damage is important in assessing cardiovascular risk in hypertensive individuals. In a 20-year follow-up of normotensive and hypertensive men, signs of end-organ damage were examined, focusing on hypertensive retinopathy. In all, 56 of the original 79 men were reexamined for hypertensive organ damage, including by digital fundus photography. The diameters of the central retinal artery equivalent (CRAE) and vein were estimated and the artery-to-vein diameter ratio calculated. Components of metabolic syndrome were assessed. Fifty percent of the normotensive men developed hypertension during follow-up. Significant differences appeared in CRAE between the different blood pressure groups (P ¼ 0.025) while no differences were observed for other markers of hypertensive organ damage. There were significant relationships between CRAE and blood pressure at baseline (r ¼ -0.466, P ¼ 0.001) and at follow-up (r ¼ -0.508, Po0.001). A linear decrease in CRAE was observed with increasing number of components of the metabolic syndrome (b ¼ -3.947, R 2 ¼ 0.105, P ¼ 0.023). Retinal vascular diameters were closely linked to blood pressures and risk factors of the metabolic syndrome. The diversity in the development of hypertensive organ damage, with changes in retinal microvasculature preceding other signs of damage, should encourage more liberal use of fundus photography in assessing cardiovascular risk in hypertensive individuals.
Introduction
Guidelines for the management of hypertension stress the importance of assessing subclinical target organ damage to enable stratification of cardiovascular risk and to guide treatment decisions. Hypertensive retinopathy refers to retinal microvascular signs that develop in response to raised blood pressure. Large epidemiological studies have shown associations between retinal vessel abnormalities and systemic disease such as hypertension, cardiovascular disease, diabetes mellitus and stroke. [1] [2] [3] [4] These studies showed a relationship between hypertensive retinopathy and current as well as past blood pressure values.
The eye is the only place in the body where it is possible to examine blood vessels of the central nervous system noninvasively and nondestructively. Physiologically, retinal arteries constrict in response to elevated blood pressure as a result of autoregulation. The primary pathologic change in hypertensive retinopathy is therefore protective vasoconstriction, generalized arterial narrowing and arterial straightening. 5, 6 International guidelines recommend examination of the optic fundus for initial evaluation of patients with hypertension, although with some variations. [7] [8] [9] The additional value of the information provided has been questioned, mainly because of the limitations caused by large interobserver variation. 10 Computer-assisted methods allow reliable and precise measurements of retinal vessel calibre from digital retinal photographs. 4, [11] [12] [13] Fouguet et al. 14 concluded that retinography allowed a more accurate stratification of cardiovascular risk in the first evaluation after diagnosis of hypertension, causing approximately 10% of the patients to be reclassified to a higher risk group. This underlies the importance of taking into account hypertensive retinopathy as target organ damage in evaluation and treatment of hypertensive individuals. The aim of this study was to analyze the relationship between blood pressure and the development of hypertensive target organ damage, with a focus on hypertensive retinopathy, in a group of normotensive and hypertensive, middle-aged Caucasian men followed for 20 years.
Methods

Study population
At baseline in 1984, 79 Caucasian men (35 hypertensive and 44 normotensive) were recruited from The Oslo Study at an age of 42.1 ± 0.5 years. The hypertensive group (n ¼ 35) consisted of men with untreated mild essential hypertension with systolic blood pressure between 140 and 170 mm Hg and/or diastolic blood pressure (DBP) between 90 and 100 mm Hg when participating in the Oslo study. Participants were included in this study if at baseline they had DBP between 94 and 105 mm Hg on two separate occasions. 15, 16 The normotensive men (n ¼ 44) were recruited from the same population, that is, from the normotensive participants in The Oslo Study, and had blood pressure below 140/90 mm Hg. All 79 men had normal ocular fundi, electrocardiograms, urinalysis and kidney function estimated by creatinine clearance.
At 20-year follow-up, all 79 individuals from 1984 were located and of these 56 (70.1%) participated in the follow-up examination: 34 of the original 44 normotensive men and 22 of the original 35 hypertensive men. In all, 7 men had died (5 normotensive and 2 hypertensive), 6 men had emigrated or moved to another county (3 normotensive and 3 hypertensive) and 10 men (2 normotensive and 8 hypertensive) did not respond or responded negatively to a letter of invitation. Those who remained normotensive through the 20-year follow-up were defined as sustained normotensive ( n ¼ 17). At the time of follow-up these men had office systolic blood pressure o140 and DBP o90 mm Hg and mean 24-h ambulatory blood pressure o125/80 mm Hg. Men who developed hypertension during the follow-up were defined as new hypertensives (n ¼ 17). They had either office systolic blood pressure X140 mm Hg or office DBP X90 mm Hg and 24-h ambulatory systolic blood pressure X125 mm Hg and 24-h ambulatory DBP X80 mm Hg or were taking antihypertensive medication (n ¼ 5) at the time of follow-up. The same criteria were used for the sustained hypertensive men (n ¼ 22) as for the new hypertensives, but they were hypertensive in 1984 as well as at 20-year follow-up. Of these 22 sustained hypertensive men, 16 (72.7%) used antihypertensive drugs. Of the 17 men defined as new hypertensives, only 5 (29.4%) were taking antihypertensive drugs. Characteristics of the study population are listed in Table 1 .
Study protocol in 1984
The study protocol in 1984 has been described earlier. 15, 16 All participants were examined in an outpatient setting by the same physicians. They were studied at the same time of day in a quiet room and at a constant room temperature. All were familiar with the clinical examination and blood pressure recording. They fasted and abstained from smoking for 8 h and from alcohol for 24 h before examination. Blood pressure was recorded semiautomatically (oscillometric technique) with an Omega 1000 Adult/pediatric blood pressure (In Vivo Research Laboratories Inc., Tulsa, OK, USA). Short Teflon catheters (Venflon, former Viggo AB, Helsingborg, Sweden) were introduced under local anaesthesia (Xylocaine without adrenaline, (Astra, Sö dertälje, Sweden)) by one investigator in the left brachial artery. The institutional committee of ethics had approved the study and informed consent was obtained from each participant.
Study protocol in 2004
The study protocol in 2004 has been described earlier. 17 The participants were studied in the same facilities as 20 years ago and at the same time of day. All were familiar with the clinical examination and blood pressure measurements. They fasted and abstained from smoking for 8 h and from alcohol for 24 h before the examination. They were all examined by the same physicians who were not aware of their previous blood pressure status. Blood pressure was measured in duplicate with a calibrated mercury sphygmomanometer after 5 min rest in a sitting position. The arm was supported at heart level and an appropriately sized cuff was used. The mean of the two measurements was used for statistical analyses. Mean blood pressure (MBP) was calculated using the formula: MBP ¼ DBP þ (pulse pressure/3). Heart rate was registered after 5 min in a sitting position. Height, weight, waist circumference and body mass index were measured and calculated using standard methods. The National Committee of Medical Research Ethics in Norway approved the follow-up study, and a concession was granted from the National Data Inspectorate in Norway. All the participants gave written informed consent.
Methods
At 20-year follow-up, digital colour fundus photographs (451, 768 576 pixels centred on the macula or optic disc) of both eyes of all participants were recorded using a retinal camera (TOPCON TRC.NW5S, TOPCON Corporation, Tokyo, Japan). The photography was performed by an experienced investigator. In 49 individuals, the quality of the photographs was sufficient to perform retinal vessel analysis. Eyes were considered ungradable if one of the six largest arteries or veins could not be measured or if the image was of poor quality (low contrast), as judged by the grader with reference to a standard image of least acceptable quality and contrast. In 39 individuals, an image of the left eye was used in the analysis and in 10 individuals an image of the right eye was used, based on evaluation of the visual quality of the images. All fundus photographs were evaluated and graded by the same experienced ophthalmologist who was unaware of the individual's blood pressure status. Retinal vessel diameters were assessed using a custom-developed semiautomatic computer programme. The vascular morphology measurement tool used the active contour model, the so-called 'snake', which is initiated by the grader and subsequently delineates the blood column at a subpixel level, and hence performs very precise measurements. This technique has been described elsewhere. 18 The vessel walls and the sleeve of plasma that surround the blood column are invisible. A standard grid containing three concentric circles was placed on the images, and only diameters of the vessels crossing the circular zone (zone B) from 0.5 disc diameter to 1.0 disc diameter from the outer rim of the optic disc were measured. The grader identified arteries and veins, using red and blue lines respectively to delineate the vessels. A segment of each vessel within zone B that was most suitable for measurement was chosen based on image quality, contrast, straightness of the vessel, and distance from branching points and crossings. When bifurcating or branching was found within the zone of interest, the trunk was preferred to the branches, unless the trunk was shorter than 80 mm. At the end of the measurement session, the computer programme identified the six widest arteries and the six widest veins and calculated the central retinal artery equivalent (CRAE) and the central retinal vein equivalent (CRVE), using the formulas developed by Knudtson et al. 19 The artery-to-vein ratio (AVR) was defined as CRAE/CRVE. Absolute distances were determined assuming a uniform vertical optic nerve head diameter of 1800 mm (Figure 1) .
Intima media thickness and plaques were measured to detect structural changes in the carotid artery. The participants were examined in a supine position with an ultrasound scanner (Acuson 128, 2 and/ or large plaques (50% stenosis). All scans were performed by the same sonographer who was unaware of the participants' blood pressure status. Echocardiography was carried out as described earlier 21 by one experienced investigator using a GE-Vingmed Vivid 7 echocardiograph (Horten, Norway) with a 1.7 MHz probe in second harmonic mode. The investigator doing the echocardiography had no knowledge of the participant's blood pressure status. End-diastolic left ventricular (LV) dimensions were used to calculate LV mass by an anatomically validated formula (r ¼ 0.9 versus necropsy LV mass). 22 LV hypertrophy was defined as LV mass index 4116 g m -2 . 23 All participants were in sinus rhythm and measurements of up to three cycles were averaged.
Definition of the components of the metabolic syndrome was based on the International Diabetes Federation criteria. 24 The variables were dichotomized. The variables used as risk factors were hypertension at follow-up, waist circumference X94 cm, fasting glucose X5.6 mmol l -1 , high-density lipoprotein cholesterol o 1.0 mmol l -1 or specific treatment for this disorder and triglycerides X1.7 mmol l -1 or specific treatment for this disorder.
Biochemical assays
Fasting blood samples were taken as described earlier. Urinary albumin excretion was determined using albumin/creatinine ratio in the first voided morning urine sample on the day of the clinical examination. Urine albumin was measured turbimetrically on a Hitachi 912 autoanalyzer, using Tinaquant reagents from Roche, Basel, Switzerland. Blood and urine samples were analyzed in a mixed order by technicians who were unaware of the participants' blood pressure status. Statistics SPSS 15.0 (SPSS Inc., Chicago, IL, USA) was used for data management and statistical analysis. Results are presented as means ± s.d. unless otherwise stated. Differences are presented as means with 95% confidence interval. Parametric tests were used for normally distributed data, while log transformations of data or nonparametric tests were applied if data were skewed. Differences between two groups were assessed either by Student's t-test or with the MannWhitney test and within-group differences with either the Student's t-test or Wilcoxon test. Comparisons between multiple groups were performed by one-way analysis of variance or Kruskal-Wallis (analysis of variance). Univariate relationships between variables were assessed by the Spearman (r) correlation coefficient or by the Pearson's correlation coefficient. A two-tailed P-value o0.05 was considered statistically significant. Multiple regression models were created with CRAE, CRVE and arteriovenous ratio as dependant variables, and MBP, haematocrit, body mass index, creatinine clearance and smoking status at baseline as independent variables. The selection of variables was Figure 1 Fundus image showing a standard grid with measured arteries and veins delineated in red and blue, respectively. The inner circle demarcates an average optic disc, the middle circle demarcates 0.5 disc diameters from the outer rim of the optic disc and the outer circle demarcates 1.0 disc diameter from the outer rim of the optic disc. Zone B was defined as the region from 0.5 disc diameter to 1.0 disc diameter from the disc margin. 
Results
In all, 56 of the 79 men were accessible for examination at 20-year follow-up, as shown in the flowchart in Figure 2 . All were Caucasian and of similar age. Characteristics of the men are given in Table 1 . Of the original normotensive participants, 17 (50%) were categorized as new hypertensives because they had developed hypertension during follow-up. Among the hypertensive individuals, 16 were using antihypertensive agents at follow-up, either monotherapy or different combinations. Twelve of these were treated with agents inhibiting the renin-angiotensin system. Retinal photographs were obtained from all 56 individuals, with quality sufficient to perform retinal evaluations in 87.5%. In the 49 individuals with usable photographs, the mean CRAEs was 156.3 ± 19.5 mm and the mean CRVEs 223.6 ± 19.5 mm. AVR ranged from 0.42 to 0.87 (median 0.70). There were significant differences in CRAE between the different blood pressure groups as shown in Figure 3 , but not with regard to CRVE and AVR (Table 1 ).
In the whole study population, significant relationships were observed between CRAE and blood pressure at baseline and at 20-year follow-up (r ¼ -0.466, P ¼ 0.001; r ¼ -0.508, Po0.001, respectively, Figures 4a and b) .
Although haematocrit differed between the blood pressure groups at baseline (P ¼ 0.012), the difference was lost at 20-year follow-up (Table 1) . Haematocrit at baseline was significantly associated with CRAE (r ¼ -0.308, P ¼ 0.032,) and AVR at follow-up (r ¼ -0.466, P ¼ 0.001, Figures 5a and b) .
A significant difference in CRVE was observed between smokers and nonsmokers at baseline. Smokers had a larger CRVE than nonsmokers (233.0 ± 20.7 mm and 219.8 ± 18.1 mm, respectively; P ¼ 0.031). There was no significant difference in CRAE and AVR between these two groups.
Fifty-one (91%) of the participating individuals had one or more components of the metabolic syndrome at follow-up. A linear decrease in CRAE was observed with an increase in the number of components of the metabolic syndrome (b ¼ -3.947, R 2 ¼ 0.105, P ¼ 0.023, Figure 6 ). Multiple regression analysis with CRAE as the dependant variable, and MBP, haematocrit, body mass index, creatinine clearance and smoking status at baseline as independent variables revealed that MBP was the only independent predictor of CRAE 
At follow-up there were no significant differences in albumin/creatinine ratio, creatinine clearance and carotid plaque score between the different blood pressure groups. There were, however, significant differences between the groups with respect to number of individuals with LV hypertrophy and diastolic dysfunction, but not with regard to LV mass index (Table 1) .
Discussion
Our data suggest that hypertensive retinopathy measured by fundus photography could be considered an early marker of hypertensive organ damage. Individuals with hypertension at 20-year follow-up had significantly more hypertensive retinopathy than those who remained normotensive. Furthermore, we found that MBP predicted CRAE at follow-up in the whole group. The observation is in keeping with those of others reporting that generalized retinal arteriolar narrowing was inversely related to current blood pressure as well as to blood pressure measured three to 8 years earlier. 2, 4, 12 This suggests that retinal arteriolar narrowing may be the result of long-term microvascular damage caused by elevated blood pressure. 12 Structural changes in the retinal vasculature have long been acknowledged as a predictor of hypertensive organ damage. 26 Our results extend these findings to a 20-year follow-up, albeit in a small group of individuals. The relationship between mean blood pressure at baseline and at follow-up and CRAE seemed stronger than the relationship between blood pressure and CRVE, implying that, as suggested earlier, the effect of blood pressure on arterioles may be more prominent than that on venules. 2, 27 Mean blood pressure at baseline ( mmHg) We did not observe a relationship between the development of hypertensive retinopathy and LV hypertrophy. Conventional echocardiography did not discriminate differences in LV mass index in the different blood pressure groups as reported earlier. 21 There were, however, significantly more hypertensive individuals than normotensives who had developed LV hypertrophy and diastolic dysfunction during the follow-up. 21 There were no differences in other markers of end-organ damage, that is, creatinine clearance, urinary albumin excretion and carotid plaque score, between the different blood pressure groups. This diversity in development of end-organ damage was somewhat unexpected but may imply that changes in retinal microvasculature precede other signs of end-organ damage. Increased urinary albumin excretion in hypertensive individuals is thought to be an early marker of renal damage, and can be reversed and influenced by antihypertensive therapy, in particular by agents that inhibit the renin-angiotensin system. The majority of the hypertensive individuals used either angiotensin-converting-enzyme inhibitor or angiotensin receptor blocker and this might at least partially explain the lack of difference in albumin excretion between the blood pressure groups.
Haematocrit as a marker of whole blood viscosity has been associated with hypertension and cardiovascular mortality. 28, 29 Whole blood viscosity has also been linked to components of the metabolic syndrome. 30, 31 In this study, we observed a strong relationship between haematocrit at baseline and CRAE and AVR. Thus, whole blood viscosity may be implicated in the development of hypertensive organ damage in addition to being predictive of development of hypertension as suggested earlier. 32 More than 90% of the study population presented with one or more components of the metabolic syndrome as defined by the International Diabetes Federation criteria. 24 The individuals with the highest number of risk factors had the smallest diameter of the retinal arteries showing the relationship between hypertensive end-organ damage and the metabolic syndrome. This novel observation, linking the number of risk factors in the metabolic syndrome to hypertensive retinopathy, indicates that not only blood pressure but also other risk factors of the metabolic syndrome need to be considered. In the Rotterdam study, 33 not only blood pressure but also cholesterol levels, atherosclerosis, high waist-to-hip ratio and inflammation markers affected the retinal vascular diameter.
In our study, smoking influenced the diameter of the retinal veins, smokers having more dilated veins then nonsmokers. This was observed earlier in large population studies, the putative mechanism being that smoking causes retinal hypoxia, causing venular dilation. [33] [34] [35] Smoking status did not influence the retinal arterial diameter in our study. This is consistent with the literature that states that smoking has little effect on arteriolar diameter or causes only mild arteriolar narrowing rather than widening. 36, 37 The strengths of the present investigation are the long observation period of 20 years and the unique homogeneity of the study population. Structural changes in the retinal vasculature are found both in hypertensive patients and in the normal ageing population. Different ages in a study population could therefore complicate interpretation of results. In our study, the men were all of the same age, making our findings easier to interpret, although the results may not be applicable to other populations. The quantitative measurement of the retinal vascular calibre and the fact that few of our participants had ungradable photographs strengthens our findings. The power of the study is limited by the small number of participants. The small number could, however, make the findings more clinically relevant. We could reexamine two-thirds of the original study population. Blood pressure at baseline did not differ between those who participated in the follow-up study and those who did not. It would therefore be fair to assume that selection errors were to a large extent avoided although a larger participation of the original group would have been preferable.
High blood pressure is a preventable risk factor for cardiovascular morbidity and mortality. Subclinical organ damage is currently regarded as an intermediate stage in the continuum of vascular diseases and a strong determinant of total cardiovascular risk in both normotensive and hypertensive individuals. Fundus photography with quantitative measurement of retinal vascular diameter might enable more accurate stratification for cardiovascular risk in 
